Cno Financial Group, INC 8-K filings

Current reports — the filing a company makes when something happens that shareholders need to know about before the next quarterly report.

NYSE
CNO Financial Group announced robust second quarter 2026 financial results, driven by strong sales momentum and improved profitability, leading to an 8% increase in full-year operating EPS guidance.
NYSE
CNO Financial Group shareholders re-elected all nine director nominees and ratified executive compensation and auditors.
NYSE
CNO Financial Group reported strong first quarter 2026 results, highlighted by a 33% increase in operating earnings per share and sustained sales momentum.
NYSE
CNO Financial Group announced a quarterly dividend of $0.17 per share and the retirement of Director Nina Henderson.
NYSE
CNO Financial Group achieved record sales and strong earnings growth in 2025, exceeding all guidance metrics and returning $386 million to shareholders.
NYSE
CNO Financial Group announced the appointment of Linda Gibson, a seasoned investment management executive, as an independent director to its Board, increasing its size to ten members.
NYSE
CNO Financial Group announced robust third-quarter 2025 financial results, including increased net operating income and record sales, alongside a raised 2027 operating return on equity target.
NYSE
CNO Financial Group presented a Consumer Division Briefing, showcasing consistent growth across its insurance and financial services segments for middle-income America.
NYSE
CNO Financial Group announced its second quarter 2025 results, reporting a decrease in net income and operating income compared to the prior year, yet highlighting strong sales momentum across its divisions and reaffirming its 2025-2027 return on equity targets.
NYSE
CNO Financial Group, Inc. has released an Investments Briefing presentation, highlighting its proven investment approach, strong asset quality, and strategic opportunities to enhance operating return on equity.
NYSE
CNO Financial Group enters into a sixth amendment and restatement agreement for its revolving credit, enhancing financial flexibility and extending the facility's maturity.
NYSE
CNO Financial Group announced its first quarter 2025 results, reporting a solid start to the year and reaffirming its full-year 2025 and three-year return on equity guidance.
NYSE
CNO Financial Group's Board of Directors has approved an additional $500 million for share repurchases and declared a $0.16 quarterly dividend.
NYSE
CNO Financial Group announces exceptional fourth quarter and full-year 2024 earnings and sales, positioning the company for sustainable growth and ROE expansion in 2025.
NYSE
CNO Financial Group has named Joel Koehneman as its new Chief Accounting Officer, effective January 21, 2025, replacing Michellen Wildin who will assist with the transition.
NYSE
CNO Financial Group announced solid third-quarter 2024 results, highlighted by a 25% increase in annuity collected premiums and a 26% rise in operating earnings per share.
NYSE
CNO Financial Group has appointed Jess Turner, a senior technology executive from Mastercard, to its board of directors, effective immediately.
NYSE
CNO Financial Group announced a significant increase in earnings per share, driven by strong sales, underwriting margins, and investment income.
NYSE
CNO Financial Group has successfully priced and closed a public offering of $700 million in senior notes due 2034, with the proceeds intended for general corporate purposes and debt repayment.
NYSE
CNO Financial Group's 2024 Annual Meeting saw shareholders elect eight directors, approve executive compensation, ratify the accounting firm, and adopt an amended shareholder rights plan.
NYSE
CNO Financial Group announced a net income of $112.3 million for the first quarter of 2024, driven by strong sales and distribution growth.
NYSE
CNO Financial Group declared a $0.15 per share quarterly dividend, announced its annual shareholder meeting date, and disclosed the retirement of a board member.
NYSE
CNO Financial Group announced strong fourth quarter earnings and sustained full-year sales momentum, driven by agent force growth and strategic initiatives.